Compare NSPR & NEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSPR | NEON |
|---|---|---|
| Founded | 2005 | 1997 |
| Country | United States | Sweden |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.7M | 27.5M |
| IPO Year | 2009 | 1994 |
| Metric | NSPR | NEON |
|---|---|---|
| Price | $0.72 | $0.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $4.00 | ★ $6.00 |
| AVG Volume (30 Days) | 85.7K | ★ 285.7K |
| Earning Date | 05-04-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 37.88 |
| EPS | ★ N/A | N/A |
| Revenue | $2,310,000.00 | ★ $3,108,000.00 |
| Revenue This Year | $57.98 | $72.74 |
| Revenue Next Year | $95.41 | $28.94 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $0.72 |
| 52 Week High | $2.93 | $29.90 |
| Indicator | NSPR | NEON |
|---|---|---|
| Relative Strength Index (RSI) | 39.07 | 37.88 |
| Support Level | $0.69 | $0.76 |
| Resistance Level | $1.04 | $1.05 |
| Average True Range (ATR) | 0.03 | 0.10 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 71.29 | 43.79 |
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
Neonode Inc provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. Its machine perception solutions are based on the MultiSensing technology platform. The company also offers optical sensing solutions for contactless touch and gesture sensing. It markets and sells its solutions mainly to customers in the automotive sector, along with other markets such as office equipment, industrial automation, medical, military, and avionics. Geographically, the company operates in Japan, South Korea, Germany, Sweden, China, and other regions, with a majority of its revenue generated from Japan.